VAI’s Institutional Biosafety Committee (IBC) reviews, approves and oversees research involving recombinant or synthetic nucleic acid molecules. The IBC meets on an as-needed basis and the meeting minutes, once approved by the committee, are made available on this public website as required by federal guidelines.